Orna Therapeutics Lays Off Staff, Shifts Pipeline
13 Nov 2024 //
BIOSPACE
Primrose Bio, ExPLoRNA Announce Partnership to Advance mRNA Medicines
03 Sep 2024 //
PR NEWSWIRE
Orna Therapeutics Appoints Frank Neumann, M.D., Ph.D., as Chief Medical Officer
12 Apr 2024 //
PR NEWSWIRE
Orna trims staff in ‘defensive reduction’ despite large financing hauls
30 Nov 2023 //
ENDPTS
Merck bets big on circular RNA, paying $150M to work with Orna
17 Aug 2022 //
FIERCEBIOTECH